1. Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014

   • Félix de la Fuente-Gonzalo
   • Jorge M. Nieto
   • Paloma Ropero

   Original Article 25 April 2019 Pages: 1537 - 1545

2. Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)—a report on phase III

   • Cathrin Niedeggen
   • Susanne Singer
   • Jens Panse

   Original Article Open access 21 May 2019 Pages: 1547 - 1559

3. Reduced peripheral blood superoxide dismutase 2 expression in sickle cell disease

   • Iakovos Armenis
   • Vassiliki Kalotychou
   • Ioannis Rombos

   Original Article 16 May 2019 Pages: 1561 - 1572

   

4. Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries

   • Miriam Levi
   • Monica Simonetti
   • Francesco Lapi

   Original Article 09 May 2019 Pages: 1573 - 1582

5. Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density

   • Ersi Voskaridou
   • Ioannis Ntanasis-Stathopoulos
   • Evangelos Terpos

   Original Article 30 April 2019 Pages: 1583 - 1592

   

6. Increased endothelial activation in α-thalassemia disease

   • Pankamol Sirivadhanakul
   • Ampaiwan Chuansumrit
   • Nongnuch Sirachainan

   Original Article 05 April 2019 Pages: 1593 - 1602

   

7. The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth

   • Brian A. Boone
   • Pranav Murthy
   • Sebastian Vogel

   Original Article 24 April 2019 Pages: 1603 - 1610

   

8. Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis

   • Paolo Strati
   • Maen Abdelrahim
   • Ala Abudayyeh

   Original Article 15 May 2019 Pages: 1611 - 1616

   

9. Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae

   • D. Nann
   • P. Schneckenburger
   • I. Bonzheim

   Original Article 28 March 2019 Pages: 1617 - 1626

   

10. Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors

    • Xin Ren
    • Yazhen Qin
    • Qian Jiang

    Original Article 14 May 2019 Pages: 1627 - 1640

    

11. CSF3R mutations were associated with an unfavorable prognosis in patients with acute myeloid leukemia with CEBPA double mutations

    • Long Su
    • SuJun Gao
    • Wei Li

    Original Article 30 April 2019 Pages: 1641 - 1646

    

12. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin

    • Motoko Yamaguchi
    • Ritsuro Suzuki
    • Naoyuki Katayama

    Original Article 19 April 2019 Pages: 1647 - 1655

    

13. Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma

    • Jaewon Hyung
    • Jung Yong Hong
    • Cheolwon Suh

    Original Article 15 April 2019 Pages: 1657 - 1664

    

14. Interim PET-CT–guided therapy in elderly patients with Hodgkin lymphoma—a retrospective national multi-center study

    • O. S. Bentur
    • E. J. Dann
    • Chava Perry

    Original Article 18 May 2019 Pages: 1665 - 1674

    

15. Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results

    • Kosuke Toyoda
    • Akiko Miyagi Maeshima
    • Yukio Kobayashi

    Original Article 28 March 2019 Pages: 1675 - 1687

    

16. Multiple myeloma in elderly patients—a Portuguese multicentric real-life study

    • Cristina João
    • Rui Bergantim
    • Paulo Lúcio

    Original Article 08 April 2019 Pages: 1689 - 1701

    

17. Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma

    • Shuji Ozaki
    • Hiroshi Handa
    • Kazuyuki Shimizu

    Original Article 02 May 2019 Pages: 1703 - 1711

    

18. PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression

    • Alberto Mussetti
    • Alessio Pellegrinelli
    • Vittorio Montefusco

    Original Article 03 May 2019 Pages: 1713 - 1720

    

19. Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy

    • Huiwen Jiang
    • Lin Liu
    • Yu Hu

    Original Article 04 May 2019 Pages: 1721 - 1732

    

20. Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation

    • Xuan Cai
    • Jin Wu
    • Xiao-Hui Zhang

    Original Article 03 May 2019 Pages: 1733 - 1742

    

21. Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma

    • Young-Woo Jeon
    • Seugyun Yoon
    • Seok-Goo Cho

    Original Article Open access 14 May 2019 Pages: 1743 - 1753

    

22. The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT

    • Martin Schmidt-Hieber
    • Gloria Tridello
    • Jan Styczynski

    Original Article 16 April 2019 Pages: 1755 - 1763

    

23. The benefit of chronic graft-versus-host disease in patients with acute myeloid leukemia relapsed after allogeneic stem cell transplantation

    • Ziwei Wang
    • Chunrong Yin
    • Jianmin Wang

    Original Article 16 April 2019 Pages: 1765 - 1773

    

24. Isolated extramedullary leukemic involvement of the heart presenting as fulminant heart failure

    • Maria Stamouli
    • Konstantinos Gkirkas
    • Panagiotis Tsirigotis

    Letter to the Editor 11 March 2019 Pages: 1775 - 1776

    

25. The prognostic value of geriatric nutritional risk index in patients with follicular lymphoma

    • Kota Mizuno
    • Tomonori Nakazato
    • Takehiko Mori

    Letter to the Editor 30 April 2019 Pages: 1777 - 1779

    

26. Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation

    • Ryo Shimizu
    • Masahiro Takeuchi
    • Shinichiro Okamoto

    Letter to the Editor 22 May 2019 Pages: 1781 - 1783

    

27. Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease

    • Yuka Kawaji
    • Hiroaki Nagata
    • Junya Kuroda

    Letter to the Editor 13 April 2019 Pages: 1785 - 1787

    

28. A novel nucleotide substitution in the 5′ untranslated region of ANKRD26 gene is associated with inherited thrombocytopenia: a report of two new families

    • Robert T. Diep
    • Kristin Corey
    • Murat O. Arcasoy

    Letter to the Editor 12 February 2019 Pages: 1789 - 1791

29. Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?

    • Emanuele Ammatuna
    • Gerwin Huls

    Letter to the Editor 25 April 2019 Pages: 1793 - 1794

30. EBV-positive mucocutaneous ulcer within colonic diverticulitis mimicking diffuse large B cell lymphoma

    • Magda Zanelli
    • Maurizio Zizzo
    • Stefano Ascani

    Letter to the Editor 15 May 2019 Pages: 1795 - 1797

    

31. Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission

    • Tatsuya Konishi
    • Noriko Doki
    • Kazuteru Ohashi

    Letter to the Editor 21 March 2019 Pages: 1799 - 1801

    

32. Correction to: Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma

    • Semra Paydas
    • Ali Ogul
    • Serkan Gokcay

    Correction 03 June 2019 Pages: 1803 - 1803